Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: Can vildagliptin protect against radiation-induced premature ovarian failure? Insights into the AMPK and AKT signaling pathways

Fig. 2

Effect of vildagliptin co-administration on radiation-induced behavioral changes. (A) Locomotor activity. (B) SAP% in Y-maze test. Data are presented as mean ± S.D (n = 8), a; significantly different from control group at p < 0.05, b; significantly different from radiation group at p < 0.05 using one-way ANOVA followed by Tukey-Kramer as a post-hoc test. (C) Passive avoidance test; Step-through latency time in training session. (D) Passive avoidance test; Step-through latency time in test session. Passive avoidance test data are presented as mean ± S.D (n = 8), a; significantly different from control group at p < 0.05, b; significantly different from radiation group at p < 0.05 using Kruskal-Wallis test followed by Dunn’s post-hoc test

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us